内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Kirn David. Director active across 1 company, notably 4D Molecular Therapeutics, Inc.. Aggregated, 19 disclosures have been recorded. Breakdown: 0 buy · 15 sells. Total volume traded: €6m. Activity tracked since 15 December 2022. The latest transaction was filed on 19 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kirn David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报19 总计
50,000 股@ US$4.14Common StockSEC:0001193125-26-361096:0
43,149 股@ US$15.3566Common StockSEC:0001193125-26-361096:1
25,927 股@ US$16.4173Common StockSEC:0001193125-26-361096:2
26,842 股@ US$10.23010.030% mcap4.4% 占其流量Common StockSEC:0001193125-26-335115:0
12,415 股@ US$10.04610.014% mcap2.1% 占其流量Common StockSEC:0001193125-26-333014:0
42,608 股@ US$12.86560.061% mcap9.4% 占其流量Common StockSEC:0001834021-26-000004:0
442 股@ US$12.83550.0006% mcap0.1% 占其流量Common StockSEC:0001834021-26-000004:2
15,283 股@ US$12.01070.020% mcap3.2% 占其流量Common StockSEC:0001834021-26-000004:1
114,746 股Common StockSEC:0001834021-26-000002:0
1,922 股@ US$10.01970.4% 占其流量Common StockSEC:0001193125-26-253740:0
11,653 股@ US$14.423.5% 占其流量Common StockSEC:0000950170-24-083303:0
12,930 股@ US$14.423.9% 占其流量Common StockSEC:0000950170-24-077944:0
92,001 股@ US$27.128252.2% 占其流量Common StockSEC:0000950170-24-014091:0
5,696 股@ US$18.40792.2% 占其流量Common StockSEC:0000950170-24-007477:0
28,632 股@ US$17.268510.1% 占其流量Common StockSEC:0000950170-24-002945:0
600,000 股0Common StockSEC:0001140361-23-023022:0
17,090 股@ US$20.93147.5% 占其流量Common StockSEC:0001567619-23-003706:0
10,899 股@ US$20.03374.6% 占其流量Common StockSEC:0001567619-23-001163:0
31,433 股@ US$23.560215.6% 占其流量Common StockSEC:0001567619-22-021815:0
About Kirn David
Kirn David is a declarant linked to 4D Molecular Therapeutics, Inc. (XNAS), with See Remarks listed as the role. He has 14 filings in total, and in the 14 sampled filings the transactions are sales, for a total of EUR 4,754,573, between 2022-12-19 and 2026-07-14.